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Summary  
Objective: Examine the expression of ILA, a member of the human NGF/TNF receptor family and the homologue of 
the murine 4-1BB, in mesenchymal cells. 
Methods: ILA mRNA was analyzed by quantitative polymerase chain reaction and Northern blotting in human 
articular chondrocytes and fibroblasts. ILA protein expression was examined by flow cytometry. 
Results: The proinflammatory stimuli interleukin-lfi (IL-lfi), tumour necrosis factor (TNF) ~, leukemia inhibitory 
factor (LIF), interferon (IFN) 7 and lipopolysaccharide (LPS) induced ILA mRNA in primary human articular 
chondrocytes. TGFfl and dexamethasone inhibited IL-1 induced ILA expression. Chondrocytes expressed the 4.8, 4.0 
and 1.9 kb isoforms of ILA mRNA which had previously been observed in lymphocytes and additional isoforms at 3.2, 
1.5 and 1.2 kb. Cycloheximide alone induced ILA mRNA in primary chondrocytes while the combination of IL-1 and 
cycloheximide resulted in ILA superinduction. 
In contrast o primary chondrocytes, activated human synovial or skin fibroblasts did not express ILA mRNA. 
Furthermore, ILA was no longer inducible by IL-1 in subcultured, dedifferentiated chondrocytes. However, repression 
of ILA in fibroblasts and dedifferentiated chondrocytes was overcome by cycloheximide and IL-1 further increased ILA 
mRNA levels in the presence of cycloheximide. 
Flow cytometric analysis of ILA protein expression with monoclonal antibodies revealed increased cell-surface 
expression on IL-1 or TNF~, but not on TGFfl stimulated chondrocytes. 
Conclusion: ILA is not only expressed in the immune system but also in mesenchymal cells. ILA expression is induced 
by specific stimuli and modulated by the differentiation status of the cells. ILA can serve as a model and marker to 
analyze differentiation-dependent gene expression in mesenchymal cells. 
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I n t roduct ion  
A GENE induced by lymphocyte act ivat ion (ILA) is 
a member of the human nerve growth factor / tumor 
necrosis factor receptor (NGF/TNF-R) family [1] 
and the human homologue of the murine gene 
4-1BB. It is now designated as CD137. While 4-1BB 
appears to be exclusively expressed in act ivated T
lymphocytes [2], ILA is also expressed outside the 
immune system [3]. 
The NGF/TNF-R receptor family includes an 
increasing number of proteins, which mediate 
diverse cell functions in development and during 
adaptive responses in mature organisms. The 
common structural  motif  of these receptors 
consists of three to six cysteine-rich regions of 
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approximately 40 amino acids in the extracel lu lar  
domain [4]. Members of this family include the 
low-affinity NGF-R [5], TNF-RI [6, 7], TNF-RI I  
[8, 9], CD40 [10], the Hodgkin 's  ant igen CD30 
[11, 12], CD27 [13], FAS/APO-1 [14, 15], the OX-40 
antigen on act ivated rat or mouse T cells [16, 17] 
and the T2 and SaIF19R open reading frames from 
the Shope fibroma [18] and the vaccinia virus [19]. 
Some of these receptors such as the TNF-R and 
Fas/Apo-1 are expressed in all organ systems while 
others appear  to be restr icted to the immune 
system. 
The receptors of this family recognize soluble or 
cell-surface bound l igands which are structura l ly  
related [20, 21]. Ligands for ILA and for 4-1BB 
that  demonstrate homology to members of this 
new cytokine family have been cloned [22, 23]. 
Act ivat ion of ILA and of 4-1BB by 4-1BB l igand 
or monoclonal  antibodies co-stimulates T cell 
prol i ferat ion [3, 23, 24]. Interact ion between ILA 
and its l igand regulates lymphocyte survival  [3]. 
TNF and NGF regulate cell prol i feration, survival  
and secretory functions in different cell types 
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[4, 25]. Stimulation of cells through the TNF-R [25] 
and the Fas/APO-1 antigen [21, 26, 27] can induce 
apoptosis. In contrast, the expression of the 
low-affinity NGF-R [28] and antibodies to CD40 
can prevent apoptosis [29]. In addition, anti-CD40 
in combination with antibody to cell-surface 
immunoglobulin promotes long-term maintenance 
of B cells [30]. CD40 ligand enhances antigen- 
independent B-cell proliferation, secretion of IgE 
[31] and T-cell help for antigen specific antibody 
responses [32]. Stimulation of CD27 [33, 34], which 
is expressed on most peripheral blood T-cells 
and mature thymocytes, and of the rat T-cell 
subset antigen OX-40 by specific antibodies or 
CD27 ligand [20] increases lymphocyte prolifer- 
ation. Furthermore, CD27 ligand promotes the 
generation of cytotoxic T cells [20]. 
The objective of the present study was to deter- 
mine whether, in addition to immune cells, ILA is 
also expressed by mesenchymal cells, and to study 
ILA mRNA regulation in these cells. It is shown 
that ILA mRNA expression is a characteristic 
of differentiated human articular chondrocytes 
while it is not expressed in skin and synovial 
fibroblasts. Flow cytometry analysis indicated that 
the ILA protein is expressed on chondrocytes and 
is upregulated by IL-1 and TNFc~. 
Mater ia l s  and  Methods  
CELL ISOLATION AND CULTURE 
Chondrocytes were isolated from articular 
cartilage which was obtained at autopsy 
from donors without history of joint disease. 
Cartilage from the femoral condyles and the tibial 
plateaus was used for the experiments. Separation 
and culture of chondrocytes was carried out 
as described earlier [35]. For studies of ILA 
mRNA expression, chondrocytes were trypsinized 
from T175 flasks and plated in six-well-dishes 
at a density of 5• and stimulated 
directly or after serum starvation for 24 h as 
indicated. 
Synovium was obtained from donors with 
rheumatoid arthritis (RA) or osteoarthritis (OA) 
undergoing total joint replacement surgery. 
The tissue was digested with collagenase and 
synoviocytes were cultured, as described in detail 
elsewhere [36]. Synoviocytes were kept in culture 
for four to six passages to obtain a uniform 
fibroblast cell population [37], and were used in 
experiments with or without preceding serum 
starvation. 
Normal human skin fibroblasts (primary 
cells, passage 0) were obtained from ATC 
(Rockville, MD, U.S.A.) and used for experiments 
at passage 1. 
RNA ISOLATION 
Total RNA was isolated by a single 
step guanidinium thiocyanate-phenol-chloroform 
method. Cells were lyzed directly in the flasks 
using RNA Stat-60 (Tel-Test 'B', Inc., Friendswood, 
TX, U.S.A.) and the samples were processed 
following the manufacturer's protocol. Poly A § 
RNA was obtained with PolyATract mRNA 
isolation system (Promega, Madison, WI, U.S.A.). 
REVERSE TRANSCRIPTION 
Total RNA (up to 5 mg) was reverse-transcribed 
in a 20/~1 volume containing 4pl 5xRT-buffer 
(BRL, Gaithersburg, MD, U.S.A.), 10raM DTT, 
500mM dNTPs, 1/~1 random hexanucleotides, 
200U MoMLV-RT (BRL) and 20U RNasin 
(Promega) for 30-120 rain at 37~ 
POLYMERASE CHAIN REACTION (PCR) 
PCR for ILA and IL-6 was performed with 2 pl of 
the reverse transcription (RT) reaction product in 
25 or 50 pl volume with 1 U Taq DNA polymerase 
(Perkin Elmer Cetus, Emeryville, CA, U.S.A.), 
140ram dNTPs and 10pM of each primer in 
10 • incubation buffer (100 mmol Tris-HCl; 15 mmol 
MgC1; 500mmol KC1; lmg/ml gelatine; pH8.3 
at 20~ 5 U/ill on an Ericomp (Ericomp, Inc., 
San Diego, CA, U.S.A.) or a Hybaid-Omnigene 
thermocycler. On the Ericomp cycler, after a 5 min 
denaturation step at 94~ the reaction proceeded 
in 35 cycles of 30" at 94~ 30" at 55~ and 1' 15" 
at 72~ followed finally by one cycle of 7' at 72~ 
On the Omnigene-cycler, a i rain denaturation step 
at 94~ was followed by 35 cycles of 5" at 94~ 20" 
at 55~ and 50" at 72~ with one final cycle of 7' at 
72~ 
PCR for GAPDH was performed on the 
Omnigene thermocycler using the following 
program: one cycle of 2' at 92~ and 1' at 60 ~ 35 
cycles of 10" at 72 ~ 5" at 92~ and 10" at 60~ and 
one cycle of 5' at 72~ 
All PCR conditions for ILA, IL-6 and GAPDH 
were within the linear range of amplification of the 
target cDNAs. 
The following PCR primers were used: ILA 
(486 bp product): sense: CAT TCC CGG GTC CTT 
GTA GTA AC (nucleotides 69-91). Antisense: CGG 
TGA TCA TCC TGG CTC TCT CGC AGG GGC 
(nucleotides 555-527). IL-6 (465 bp product): sense: 
CAC AGA CAG CCA CTC ACC TCT TC 
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(nucleotides 43-65). Antisense: TGT TGA GAT 
GAG TAA GAC GCG TCG (nucleotides 507-484). 
GAPDH (190 bp product): sense: TGG TAT CGT 
GGA AGG ACT CAT GAC. Antisense: ATG CCA 
GTG AGC TTC CCG TTC AGC. 
COMPETITIVE PCR 
To prepare a template for quantitative PCR 
a 200bp deletion was introduced into the ILA 
cDNA by PCR-mediated mutagenesis. ILA cDNA 
(position 1 until position 921), cloned into the 
EcoRI and Sinai site of pGEM 7c (Promega) 
between the SP6 (5' end) and T7 (3' end) promoter 
was taken as a template for two separate PCR 
reactions. First, two fragments, one starting at the 
SP6/5'-end, and one starting at the T7/3'-end were 
created with the following primer pairs: (1) 5' SP6 
primer (InVitrogen, San Diego, CA, U.S.A.) and 
TGC CTG CAT ATG TCA CAG 3' (ILA Del 1), 
(2) 5' GAC CTG TGA CAT ATG CAG GCA 
GAC CCT GGA CAA ACT G(ILA Del 2) and T7 
primer 3' (InVitrogen). 
As the ILA del 2 primer sequence contained 
a 22bp overlap with the 3' end of the ILA del 1 
primer the fragments from both PCR reactions 
were annealed in a subsequent amplification using 
the SP6 and T7 primers. The resulting new 
template contained a 200 bp deletion between the 
ILA de] 1 and 2 primers. This fragment was cloned 
into the EcoRI and HindIII sites of pGEM4z. Serial 
dilutions of the plasmid were used as competitor 
cDNA in quantitative PCRs. 
For amplification of target and competitor 
cDNA in quantitative PCR experiments, a sense 
primer different from the one in non-quantitative 
PCR was used: GAG AAT TCC ATG GGA ACC 
AGC TGT TAC (nucleotides -9 to 18), which 
together with the antisense primer amplified a 
564 bp product. 
Single-stranded cDNA was coamplified with 
serial dilutions of the deletion clone on the 
Ericomp thermocycler. PCR products were 
separated on 1.5% agarose gels and stained 
with ethidium-bromide. Pictures were taken 
with a Land MP4 Polaroid camera using 
Polaroid #667 films. Prints were scanned on 
a Mikrotek MSF-300G scanner (Microtek Inter- 
national Inc., Taiwan) and bands were sub- 
sequently analyzed using NIH Image 1.44 software. 
Relative densities of target and competitor cDNA 
bands were calculated after correcting for the 
intensity of background. The ratios of target to 
competitor products were plotted against the 
number of competitor molecules present in the 
reaction. 
DNA BLOTTING 
For demonstration of specific ILA-cDNA, RT. 
PCR products were separated on 1% agarose gels. 
transferred to Hybond-membranes (Amersham, 
Arlington Heights, IL, U.S.A.) and cross-linked 
with UV-light for 5 rnin each side. After pre- 
hybridization with salmon sperm RNA at 42~ 
for 2h, hybridization was performed overnight 
at 42~ using a '~P-CTP-labeled ILA full-length 
cDNA-probe in 50% formamide, 0.2% sodium 
dodecyl sulphate (SDS), 2.5xDenhardt's solution 
and 3 x SSC. After washing twice at room tempera- 
ture for 15 min, once for 15 min at 40~ and once 
for 15min at 65~ in lxSSC, 0.1% SDS and 
0.1 zSSC, 0.1% SDS, the damp filters were exposed 
to Kodak XAR films for 30 rain to 3 h. 
RNA BLOTTING 
Ten micrograms of poly-A + RNA were separated 
on 0.8% formaldehyde gels, transferred onto 
Zeta-Probe membranes (Bio-Rad, Richmond, CA, 
U.S.A.), and UV-cross-linked. Hybridization probes 
were prepared by nick-translation (Amersham) of 
a 486 bp ILA cDNA (nucleotides 69-555), which 
had been amplified by PCR from a full-length, 
sequenced ILA cDNA clone [1] and subsequently 
purified from agarose gels. RNA loads on the filters 
were determined by control hybridizations with a 
full-length cyclophilin cDNA probe [91. Blots were 
prehybridized in hybridization buffer (5xSSC, 
5 • 50 mM NaPO.~, pH 6.8, 10 mM EDTA, 
1% SDS, 50 pg/ml herring testis DNA, 200 pg/ml 
yeast RNA) at 65~ Hybridization was performed 
overnight in prehybridization buffer containing 
10 (~ cpm/ml of the corresponding 3~P-labeled cDNA 
probe, followed by washes in IxSSC, 0.2% SDS 
at room temperature (2x15'), 0.2xSSC, 0.2% 
SDS (2 x 15', room temperature) and final washes in 
0.1xSSC, 0.2% SDS at 65~ (2x15'). Filters were 
exposed to Kodak XAR film at -70~ for 1--16 h. 
PRODUCTION OF  ANTI - I LA  MONOCLONAL ANTIBODIES 
Full-length I LA  cDNA was  cloned into the 
pRc /CMV (InVitrogen) vector. E ight-week old 
Balb-C mice were immunized  three times at 
biweekly intervals with 20 fig of expression vector. 
Spleenocytes were fused to P3X63Ag8U. I  (ATCC)  
mye loma cells according to standard proce- 
dures. Hybr idoma supernatants were screened 
by Western  blot on a bacterial glutathione-S- 
transferase (GST)/ILA bacterial fusion protein 
which was prepared as follows. 
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A cDNA fragment encoding the extracel lular 
domain of iLA was inserted into the prokaryotic 
expression vector pGEX-3X (Pharmacia, Piscat- 
away, NJ, U.S.A.) in frame with the GST-gene. 
The chimeric fusion protein (pGEX-ILA) was then 
used for the screening of hybridoma supernatants. 
Monoclonat antibodies recognizing GST/ILA on 
Western blot were used for flow cytometry. 
FLOW CYTOMETRY 
Cells were detached from plastic culture dishes 
with PBS containing 10 mM EDTA, stained with 
1 tlg/ml propidium-iodide (PI) for 15 min at room 
temperature, washed, fixed for 15 min at 4~ in 2% 
paraformaldehyde washed again and resuspended 
in staining media (SM; RPMI, containing 3% FBS 
and 0.01% NAN3) either containing saturat ing 
amounts of monoclonal antibody or mouse isotype 
control. After 45 min at 4~ cells were washed 
with SM, then stained for 30min at 4~ with 
sheep anti-mouse Ig FITC-conjugated antibody 
(Boehringer, Indianapolis, IN, U.S.A.) and after 
further washing analysed on a flow cytometer 
(FACScan~; Becton Dickinson & Co). Dead cells 
staining with PI were excluded from analysis. 
experiments examined whether fibroblasts, as an 
example of a mesenchymal cell type, express this 
gene. Two types of fibroblasts were analyzed as 
unstimulated cells and after activation with a 
broad spectrum of stimuli. Human skin fibroblasts 
(passage 1) did not express ILA mRNA constitu- 
tively nor after activation with IL-lfi or TGFfi 
(Fig. 1). Synovial fibrobasts were treated with 
additional stimuli including TNFe, lipopoly- 
saccharide (LPS), LIF and IFN?, and combinations 
of these but this also failed to induce detectable 
levels of ILA mRNA (not shown). The ability 
of these stimuli to activate the fibroblasts was 
z~ 4 s9 4 
(a) 
ILA 
COLLAGEN IMMUNOHISTOCHEMISTRY 
Chondrocytes at different passages were cul- 
tured on eight-chamber slides, fixed and stained 
with goat anti-human type II collagen as described 
[38]. 
REAGENTS 
The cytokines inter leukin (IL)-lfi, TNF~, 
leukemia inhibitory factor, (LIF), transforming 
growth factor (TGF)fil, IL-6, IL-8, IL-10, IL-11, 
platelet-derived growth factor (PDGF) AA and 
interferon (IFN) 7 were purchased from R&D 
Systems (Minneapolis, MN, U.S.A.). Endotoxin 
content was less than 0.1ng/mg of cytokine 
protein. LPS from Salmonella Minnesota, cyclo- 
heximide, dexamethasone, and all trans retinoic 
acid were purchased from Sigma (St. Louis, MO, 
U.S.A.). 
Results 
HUMAN SYNOVIAL  AND SK IN  F IBROBLASTS DO NOT 
EXPRESS ILA  CONSTITUT IVELY  OR AFTER ACT IVAT ION 
I LA  mRNA expression is a stimulus specific 
and activation dependent function of human 
lymphocytes and monocytes  [1]. The  first set of 
(b) 
IL-6 
(c) 
GAPDH 
FIG. 1. ILA mRNA expression is not inducible in skin 
fibroblasts. Human skin fibroblasts (passage 1) were 
stimulated for 18 h with 5 ng/ml IL4fl, 10 ng/ml TGFfll 
and a combination of both. Total RNA was extracted and 
reverse transcription to cDNA was performed, followed 
by PCR using ILA-specific primers. Amplification 
products were separated on 1.5% agarose gels and 
visualized by ethidium bromide staining (a). To exclude 
that the lack of ILA induction was due to inadequate 
cell activation by the different stimuli, IL-6 cDNA was 
amplified (b). Equal amounts of RNA in the different 
samples were demonstrated byPCR-amplification of the 
constitutively expressed GAPDH (c). No constitutive 
expression or induction of ILA mRNA by IL-lfi, TGFfl or 
the combination of both was seen. Constitutive l vels of 
IL-6 were increased by IL-1 and the combination of IL-1 
and TGFfl. 
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demonstrated by the induction of IL-6 mRNA 
(Fig. 1). 
These results uggested that  ILA expression is 
not a constitut ive nor an inducible function of 
normal human skin or synovial fibroblasts. 
IL-lfi ACTIVATED CHONDROCYTES EXPRESS MULTIPLE 
ISOFORMS OF ILA mRNA 
Chondrocytes are also of mesenchymal origin 
but express certain genes that  are not inducible 
in fibroblasts. Studies on the regulat ion of gene 
expression in chondrocytes have previously shown 
that IL-1 is a potent chondrocyte act ivator,  which 
induces genes that  are associated with inflam- 
mation and extracel lular matr ix degradat ion [39]. 
IL-lfl induced expression of ILA steady-state 
mRNA in pr imary human art icular  chondrocytes 
from all donors tested that  had been cultured only 
for 24 h following islation from carti lage. This was 
observed with cells st imulated in the presence of 
serum or in the absence of serum after serum 
starvation, and was not related to the varying 
levels of const itut ively expressed ILA mRNA. 
Approximately 20% of pr imary chondrocyte cul- 
tures contained PCR-detectable ILA mRNA in 
the absence of cytokine st imulat ion (not shown). 
The IL-lfl response was time dependent (Fig. 2), 
with a clearly detectable induction of ILA by 4 h 
and maximal expression by 12 h. ILA mRNA was 
IL-I~: 0 4 8 12 50 80 h 
(a) 
ILA 
(b) 
GAPDH 
FIG. 2. IL-lfl induces time dependent ILA mRNA 
expression in chondrocytes. Human articular chondro- 
cytes (passage 1) were stimulated for 16 h with 5 ng/ml 
of IL-lfi. Total RNA was extracted, reverse transcribed 
and PCR products were demonstrated on an agarose 
gel with ethidium bromide (a). The amount of cDNA in 
each condition was estimated by PCR amplification of 
GAPDH (b). Stimulation by IL-lfl was long lasting and 
ILA mRNA was still present after 80 h of stimulation. 
(a) 
Co IL-I~ 
-- 4.8 KB 
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Fro. 3. Analysis of ILA mRNA isoforms in human 
articular chondrocytes. Primary chondrocytes were 
cultured in the presence of medium or 5 ng/ml of IL-lfl. 
Poly-A§ was extracted and subjected to Northern 
blot analysis using a nick-translated 486bp cDNA 
probe (a). To exclude different amounts of RNA, control 
hybridizations were performed using a cyclophilin 
cDNA probe (b). ILA transcripts at 4.8, 4.0, 1.9, 1.5 and 
1.2 kb were induced by IL4fl after 16 h of stimulation. 
detectable for >80 h. The I L4  effect was dose 
dependent and occurred with an EDs0 between 5 
and 50 pg/ml (data not shown). 
Northern blott ing was performed to character ize 
the isoforms of ILA mRNA. Analysis of poly-A + 
RNA from pr imary chndrocytes with an ILA cDNA 
showed that  there was no hybridizat ion to RNA 
from unst imulated cells (Fig. 3). IL-1 t reatment  of 
the cells induced mRNAs at 4.8, 4.0 and 1.9kb. 
These forms of ILA mRNA are identical to those 
seen in act ivated lymphocytes [1]. In addition, 
chondrocytes contained transcr ipts at 3.2, 1.5 
and 1.2kb which have not been detected in 
lymphocytes (Fig. 3). 
These results suggest hat  IL-1 act ivated chow 
drocytes express ILA mRNA and that  these cells 
contain isoforms that  were not found in lympho- 
cytes. 
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ILA EXPRES~ON IS A STIMULUS-SPECIFIC FUNCTION 
OF ACTIVATED PRIMARY CHONDROCYTES 
We then examined whether other proinflamma- 
tory stimuli or TGFfl which is qualitatively distinct 
and induces chondrocyte prol i feration and extra- 
cellular matrix formation are also able to induce 
ILA. TNFc~, LIF, IFN?~, LPS (Fig. 4) and IL-6 (not 
shown) increased ILA mRNA levels. Other cyto- 
kines including IL-8, IL-10, IL-11 or PDGF had no 
detectable ffects (data not shown). Specificity of 
PCR-amplified cDNA was confirmed by hybridiz- 
ation with a 32p-CTP-labeled ILA-cDNA probe 
[Fig. 4(c)]. 
TGFfi was further evaluated as a potential  
negative regulator of ILA expression since it did 
not induce ILA expression by itself and has been 
shown to inhibit some of the IL-1 induced genes in 
chondrocytes [40, 41]. When added simultaneously 
with IL-1, TGFfi inhibited ILA mRNA levels by 
approximately 50% (Fig. 4). 
Retinoic acid (RetA) and dexamethasone 
(Dex) can directly affect gene expression or 
modulate the effects of other inducers. RetA 
suppresses the expression of collagen type II, 
and thus induces a dedifferentiated fibroblastoid 
phenotype in chondrocyte cultures [42, 43]. 
Treatment of chondrocytes with RetA or Dex 
for 12, 24 and 48h did not induce ILA mRNA 
(data not shown). To determine the influence of 
these hormones on IL-1 induced ILA expression, 
cells were preincubated with RetA and then 
stimulated with IL-1. Even after 72 h pretreat- 
ment with RetA, the effect of IL-1 on ILA 
induction was not reduced (Fig. 5). Dex, how- 
ever, almost completely abrogated IL-l- induced 
ILA-expression. 
(b) 
(a) 
ILA 
(c) 
GAPDH 
!i 
ILA 
Fro. 4. Proinflammatory activators induce ILA mRNA expression in chondrocytes. Chondrocytes (passage 1) were 
treated for 16 h with the following mediators: 5 ng/ml IL-lfl, 10 ng/ml TGFfil, 500 U/ml IFNg, 1000 U/ml TNFa, 10 ng/ml 
LIF, 1 tlg/ml LPS. PCR experiments were carried out using primers for either ILA (a) or GAPDH (b). ILA mRNA 
expression was strongly induced by IL-lfl, TNFa, LIF, LPS and, to a lesser extent, by IFNg. TGFfi alone did not induce 
ILA mRNA but reduced IL-lfl-induced ILA expression during coincubation. To confirm specificity of transcripts, the 
PCR-products obtained with ILA primers were submitted to Southern blot analysis using a 32p-labeled ILA full-length 
cDNA (c). 
400 von Kempis et al.: Differentiation-dependent andstimulus-specific expression of ILA 
ILA 
J 
(a) 
0.2 
(b) 
GAPDH 
FIG. 5. Regulation of ILA expression by retinoic acid and 
dexamethasone (Dex) in chondrocytes. The influence 
of retinoic acid (RetA) and Dex on the expression of 
ILA mRNA was analyzed. Subcultured chondrocytes 
(passage 2) were preincubated with 10 G M retinoic 
acid for 72 h. The cells were then treated with 5 ng/m of 
IL-lfi or I pg Dex for 16 h and reverse-transcribed ILA
cDNA was amplified by PCR (a). GAPDH expression 
was used a control (b). RetA and the combination of 
RetA and Dex did not induce ILA expression. The 
induction of ILA mRNA by IL-1/3 was not influenced by 
preincubation with RetA. The addition of Dex signifi- 
cantly reduced IL-1/3 induced ILA mRNA steady-state 
levels. 
serial dilutions of a 200 bp deletion clone of the 
ILA full-length cDNA was performed (Fig. 6). 
Control cells did not show detectable amounts of 
ILA (not shown). The equivalence point (1:1 ratio) 
O 
o 
0.1 9 9 
-0.1 
-0.2 
3.5 
"', f 
4 4.5 5 5.5 6 
Logl0 competitor (molecules) 
(b) 1 2 3 4 5 6 7 8 
These results suggest hat ILA can be expressed 
as an inducible and stimulus-specific function of 
differentiated chondrocytes. 
NEGATIVE REGULATORS OF ILA GENE EXPRESSION 
IN CHONDROCYTES 
To determine whether the IL-1 effects on ILA 
mRNA expression were dependent on protein 
synthesis, we tested the protein synthesis inhibitor 
cycloheximide (CHX). Interestingly, CHX alone 
resulted in ILA mRNA accumulat ion in primary 
chondroeytes suggesting the presence of one or 
more labile regulatory protein(s) control l ing 
ILA mRNA levels. CHX did not inhibit the IL-1 
effects but the combination of IL-1 and CHX 
resulted in ILA mRNA superinduction. For 
quantitative analysis of ILA mRNA levels a 
competitive RT-PCR using coamplification of 
FIG. 6. ILA mRNA accumulates after treatment of 
chondrocytes with CHX. Primary chondrocytes were 
treated for 16 h with 1 ng/ml IL-lfl, 50 pg/ml CHX and 
the combination of both. Quantitative PCR was 
performed and photographs ofethidium bromide-stained 
gels containing PCR products of target and competitor 
cDNA were scanned and regression analysis of the 
values was performed. Amounts of competitor molecules 
present in each reaction were determined by extrapol- 
ation (dotted lines) from the intersection of the 
regression lines with the equivalence point where the 
target:competitor cDNA ratio is 1 to the x-axis (a). As 
compared with the similar numbers of ILA mRNA copies 
expressed by cells stimulated with either IL-1 or CHX, 
induction of ILA by the combination of IL-lfl and CHX 
was increased 10-fold. Panel B shows the ethidium-bro- 
mide stained gel containing the samples from IL-1 plus 
CHX treated chondrocytes. Constant amounts of target 
eDNA were co-amplified with eight serial dilutions 
(twofold) of competitor cDNA ranging from 7.9• 105 t o: 
3.2x103 molecules (lanes 1-8). The upper and lower' 
bands in each lane represent the 564 and 364 bp products 
of target and deletion competitor, espectively. 
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of target  to competitor molecules was reached at 
1• 104 competitor molecules for the samples from 
cells treated with either IL-1 or CHX. Cells t reated 
with the combinat ion of CHX and IL-1 contained 
1 • 10 ~ molecules, representing a 10-fbld increase in 
ILA mRNA copy numbers. 
I (a) 
[ 
EXPRESSION AND REGULATION OF ILA PROTEIN  
ON CHONDROCYTES 
The ILA cDNA sequence predicts a type I 
t ransmembrane protein with three cysteine rich 
extracel lular domains. Monoclonal  antibodies 
were prepared and shown to specifically react  
with a GST-ILA fusion protein. These monoclonal  
antibodies were used in flow cytometric studies 
to determine whether chondrocytes translate ILA 
mRNA and express it as a t ransmembrane protein. 
As compared with mouse isotype ant ibody control, 
unst imulated chondrocytes howed constitut ive 
levels of ILA protein [Fig. 7(a)]. Protein levels 
were upregulated after incubation with IL-1. 
In contrast, and consistent with the effects on ILA 
mRNA, TGFfl did not increase protein expression 
[Fig. 7(b)]. TNF~ also increased ILA protein levels 
and analysis of kinetics showed that  its effects 
were maximal  after 20 h while the IL-1 effect had 
a later maximum after 70 h (data not shown). 
NEGATIVE  REGULATORY FACTORS OF ILA EXPRESSION 
ARE DOMINANT IN LATE PASSAGE CHONDROCYTES 
AND IN F IBROBLASTS 
Following repeated subcultur ing and as a 
function of t ime in culture, chondrocytes undergo 
morphologic and functional changes to a fibro- 
blastoid phenotype [44-48]. A marker  for this 
change is the expression of col lagen I I  which 
decreases after approximately 2 weeks of mono- 
layer culture [47]. We util ized this to determine 
whether ILA expression is a function of the 
chondrocyte differentiation status. With increas- 
ing time in culture, the levels of IL-1 induced ILA 
decreased, and in cells that  had been in culture for 
approximately 8 weeks ILA was no longer 
detectable after IL-1 st imulation, a l though the 
cells still responded to this cytokine with the 
production of IL-6 mRNA (Fig. 8). 
Mechanisms responsible for the selective 
expression of this gene in chondrocytes were then 
analyzed based on the results on the regulat ion 
of ILA expression. As shown above, different 
combinations of stimuli did not cause detectable 
ILA induction in fibroblasts. The accumulat ion of 
ILA mRNA in chondroeytes after t reatment  with 
CHX suggested the presence of a labile protein as 
(b) 
101 10 2 10 3 10 4 
F luorescence  in tens i ty  
Fro. 7. Flow cytometric demonstration of ILA protein 
expression. Chondrocytes (passage 1) were cultured in 
the absence or presence of IL-1 [5 ng/ml, (a) or TGF~I 
[10 ng/ml, (b)]. The cells were collected after 72 h and 
stained with monoclonal antibody to ILA or mouse 
isotype control Ig followed by FITC-conjugated sheep 
anti-mouse Ig. Cells were analyzed by flow cytometry 
and results are shown as mean fluorescence intensity. 
The results shown are representative of five separate 
experiments where upregulation of ILA by IL-1 was 
demonstrated and two experiments which showed that 
TGFfl does not detectably alter ILA protein expression. 
a negative regulator of I LA  mRNA expression. We 
thus examined  whether  this regulatory mechan ism 
was  responsible for the lack of I LA  expression in 
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(a) 
z 
ILA 
Chon Syn Fib Skin Fib 
(b) 
IL-6 
(c) 
GAPDH 
FIG. 8. Transcriptional control of ILA mRNA expression i  dedifferentiated chondrocytes, ynovial fibroblasts and skin 
fibroblasts. The effect of IL-lfl, cycloheximide (CHX) and a combination of both on ILA mRNA levels was determined 
in late passage (passage 4) chondrocytes (Chon), late passage (passage 6) synovial fibroblasts (Syn Fib) and early 
passage (passage 1) skin fibroblasts (Skin Fib). Cells were cultured for 16 h in the presence of 5 ng/ml IL-1, 50 pg/ml 
CHX and a combination of both. Reverse transcribed cDNA was amplified using primers for ILA (a), IL-6 (b) and 
CAPDH (c). ILA mRNA expression was not stimulated in all three cell populations by IL-lfl while IL-6 expression was 
strongly induced. CHX lead to accumulation of steady state mRNA of both ILA and IL-6. The expression of ILA and 
IL-6 mRNA by treatment with CHX was superinduced in the presence of IL-lfl in al three cell types. 
IL-1 treated fibroblasts and subcultured chondro- 
cytes. In chondrocytes that  had been in culture for 
more than 8 weeks, a point where they no longer 
expressed etectable type II col lagen by immuno- 
histochemistry (data not shown), CHX induced 
clearly detectable ILA mRNA levels and even 
higher levels were seen with the combinat ion of 
IL-1 and CHX in these dedifferentiated chondro- 
cytes (Fig. 8). Similar findings were obtained 
with synovial and skin fibroblasts, where CHX 
but not IL-1 induced ILA mRNA accumulat ion.  
Co-incubation with IL-1 and CHX also resulted in 
synergistic effects in these cells. 
These results indicate that  negative regulatory 
factor(s) are responsible for the differences in IL-1 
induction of ILA mRNA between pr imary chondro- 
cytes, subcultured chondrocytes and fibroblasts. 
In the latter cell types these negative factors 
are dominant and cannot  be overcome by IL-1 or 
other stimuli. In contrast,  inhibitory factors also 
modulate ILA mRNA expression in primary 
chondrocytes but  in these cells IL-1 st imulation 
can overcome their  effect. 
Discuss ion  
ILA was or ig ina l ly ident i f ied as a mRNA that 
was present in act ivated but not in resting T 
lymphocytes [1]. The ILA cDNA includes three 
cysteine-rich motifs that  are character ist ic  of the 
NGF/TNF-R family [4]. Sequence analysis revealed 
a high degree of homology in this cysteine- 
r ich extracel lular egion which makes ILA the 
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probable human homologue of the murine 4-1BB 
[1]. The members of the NGF/TNF receptor family 
differ with respect o the levels of their constitu- 
tively expressed mRNAs, and also with respect 
to the spectrum of tissues that can express the 
receptors. CD27, CD30, OX-40 and 4-1BB are 
restricted to the immune system or specific 
lymphocyte subsets. In contrast, Fas, the two 
TNF-R and the low-affinity NGF-R have a 
relatively wide tissue distribution. In the present 
study we found that ILA is expressed in chondro- 
cytes and thus classified ILA as a member of 
the NGF/TNF-R family with a broader tissue 
distribution. Northern blotting revealed ILA 
mRNA isoforms at 4.8, 4.0 and 1.gkb in IL-1 
activated chondrocytes. These forms of ILA mRNA 
are identical to those seen in activated lympho- 
cytes [1]. In addition, chondrocytes contained 
transcripts at 3.2, 1.5 and 1.2 kb which have not 
been detected in Iymphocytes. This large number of 
mRNA isoforms is remarkable. The bands detected 
by Northern blotting are not likely to represent 
other members of the NGF/TNF receptor family 
since the hybridizations were performed under 
stringent conditions. Furthermore, none of the 
bands were detected in unstimulated cells and all 
were IL-1 inducible. The functional consequence 
of these multiple mRNA isoforms is unknown. 
It is possible, however, some of these mRNAs are 
encoding a soluble form of the receptor. 
ILA mRNA was found at low constitutive l vels 
only in a minority of chondrocyte samples but 
in most cases was dependent on cell activation. 
The other members of this family which are found 
outside the immune system are generally expressed 
in unstimulated ceils. We found that, for example, 
two mRNAs encoding the two TNF-R are expressed 
in unstimulated chondroeytes at comparatively 
high levels (not shown). The expression of high 
levels of ILA mRNA in stimulated chondrocyte 
provided a suitable system for detailed analysis of 
regulatory mechanisms. 
Experiments addressing the extracellular stim- 
uli that can induce ILA expression characterized 
the inducers as those that have the common 
feature of inducing catabolic responses in chondro- 
cytes and cause cartilage degradation. IL-1, TNF, 
LIF and LPS which induce the production of 
other proinflammatory cytokines and matrix 
metalloproteinases were the most potent inducers 
of ILA. TGFfi, a prototypic anabolic factor in 
cartilage which induces chondrocyte proliferation, 
the synthesis of tissue inhibitors of metallo- 
proteinases (TIMP) and extracellular matrix [39], 
did not induce ILA. PDGF, an additional chondro- 
cyte growth factor also did not detectably 
stimulate ILA expression (not shown). This pattern 
of inducibility by qualitatively distinct extracellu- 
lar stimuli indicates that ILA may be associated 
with the proinflammatory and catabolic functional 
program in chondrocytes. This notion is further 
supported by the finding that IL-1 induction of ILA 
was significantly inhibited by TGF~. Most genes in 
chondrocytes are sensitive to regulation by these 
two cytokines and can be classified as those that 
are induced by either IL-1 or TGFfi, genes that are 
synergistically induced by the combination of IL-1 
and TGF/3 and a group where IL-1 and TGFfi act 
antagonistically [39]. ILA is highly sensitive to 
inhibition by TGFfi since simultaneous addition 
IL-1 and TGFp is sufficient for inhibition while for 
other genes that are antagonistically regulated, 
preincubation of the cells with TGFfi is required to 
obtain inhibition. 
Studies on second messenger agonists showed 
that diverse signals including activation of PKC, 
elevation of intracellular cAMP and calcium 
can trigger ILA mRNA accumulation. Synergy 
was seen with combinations of these agonists 
but this did not reach the high levels of ILA 
that are stimulated by IL-1 (data not shown). It is 
likely that tyrosine kinase activation is necessary 
since the IL-1 expression of nitric oxide synthase, 
another gene that is selectively expressed by 
chondrocytes and not fibroblasts [49], as well as 
other IL-1 induced genes in chondrocytes are 
blocked by pharmacologic inhibitors of protein 
tyrosine kinases (unpublished). 
Monoclonal antibodies that were raised by 
DNA immunization with ILA expression vectors 
recognized ILA protein on the cell surface of 
chondrocytes. Unstimulated cells showed variable 
levels of constitutive expression and in response to 
IL-1 and TNF there was consistent upregulation. 
In contrast, TGF~ did not detectably alter the 
levels of ILA protein. These results suggest hat 
chondrocytes translate ILA mRNA and express it 
as a cell membrane protein. The differential effects 
of these cytokines on protein expression are 
consistent with the findings on mRNA regulation. 
Future studies with these antibodies will address 
the role of ILA in the regulation of chondrocyte 
function. 
Fibroblasts were analyzed as another 
mesenchymal cell type but none of the extra- 
cellular stimuli or second messenger agonists that 
were tested induced ILA mRNA. This was observed 
with primary skin fibroblasts and with subcultured 
synovial fibroblasts. ILA can thus be considered 
as a gene that is expressed by chondrocytes, 
and the finding that it is not inducible by IL-1 
in subcultured chondrocytes suggests that it is 
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a marker  of differentiated chondrocytes. More 
importantly,  the results obtained by teatment with 
CHX provide at least a part ia l  explanat ion for 
the dif ferentiat ion-dependent xpression of ILA. 
In pr imary chondrocytes we found that  CHX did 
not inhibit  the IL-1 induction of ILA but lead to 
mRNA accumulat ion.  Moreover,  the combinat ion 
of IL-1 and CHX resulted in super induct ion of ILA 
mRNA. This indicated that  one or more labile, 
negative regulatory protein(s) control  the levels 
of ILA mRNA. In pr imary chondrocytes IL-1 can 
overcome its effects. However, in dedifferentiated 
chondrocytes and in fibroblasts dominance of this 
regulator(s) may block IL-1 induction of ILA 
mRNA. Inhibit ion of protein synthesis and of this 
regulator  by CHX then induces ILA mRNA. As 
seen in pr imary chondrocytes, IL-1 leads to higher 
levels of ILA mRNA in the presence of CHX as 
induced by CHX alone suggesting that  the effect of 
IL-1 on ILA mRNA under these condit ions is 
independent on de-novo synthesis of proteins. 
These findings on chondrocytes and fibroblasts are 
in contrast  to lymphocytes, where ILA induction 
by mitogens was prevented by CHX indicating that  
the negative regulatory protein is absent or not 
dominant in these cells [1.]. 
Although the factor responsible for the CHX 
effects has not been identified, it is conceivable 
that  the activity that  reduces ILA mRNA in 
pr imary chondrocytes and prevents expression in 
dedifferentiated chondrocytes and fibroblasts are 
related. This would suggest hat  in these latter cell 
types the activity is dominant and may regulate the 
expression of ILA and possibly other genes during 
mesenchymal  cell differentiation. Only l imited 
information is avai lable on transcr ipt ional  modu- 
lators of mesenchymal cell differentiation. Studies 
on potential  interact ions of the recently identified 
cart i lage homeoprotein I [50] and the CHX- 
sensit ive negative regulator  of ILA expression may 
provide initial insight into mechanisms of differen- 
t iat ion-dependent gene expression in mesenchymal  
cells. 
In conclusion, these results demonstrate that  
ILA, a new member of the human NGF/TNF-R 
family is not only expressed in the immune system 
but also in chondrocytes. In chondrocytes, ILA 
expression is induced by fators that  induce 
cart i lage destruction but not by TGFfi, a proto- 
typic stimulus for cart i lage formation. Al though 
the role of ILA in the regulat ion of chondrocyte 
function remains to be established, this response 
pattern to extracel lular stimuli suggests that  
ILA may be involved in the catabol ic program in 
chondrocytes. The cell type-dependent differences 
in ILA expression character ize ILA as a marker  
that  allows differentiation of chondrocytes and 
fibroblasts. The finding that  a negative regulator  
of ILA mRNA expression is at least in part  
responsible for these differences provides a model 
for further studies on the molecular mechanisms of 
mesenchymal cell differentiation. 
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